ArticleAnalytical chemistry2026
Profiling Glycoproteins Enriched by Multinanoparticle Protein Corona.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- GlycoDiveR: A Modular R Framework to Analyze and Visualize Highly Dimensional Glycoproteomics Data.ACS measurement science au · 2026Article
- UnderstandingJournal of the American Society for Mass Spectrometry · 2026Article
- GlycoDiveR: a modular R framework to analyze and visualize highly dimensional glycoproteomics data.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Biofluids, such as plasma and cerebrospinal fluid (CSF), present significant challenges for proteome and glycoproteome analysis due to their complex protein composition and wide dynamic range of protein abundances. Nanoparticle (NP)-based enrichment methods that rely on the formation of protein coronas to compress dynamic range have emerged as promising approaches to improve the proteomic sampling depth in biofluids, yet implications of these methods for glycoproteome characterization remain underexplored. In this study, we investigate enrichment via multinanoparticle protein corona (abbreviated here as NP enrichment) with and without subsequent mixed-mode anion exchange (MAX) enrichment for characterizing N- and O-linked glycopeptides in human plasma and CSF. Using an automated commercial platform, we demonstrate that NP enrichment significantly enhances N-glycoproteome coverage, particularly in plasma, and increases detection of N-glycopeptides from low abundant glycoproteins. These N-glycoproteome improvements are further enhanced when combined with MAX enrichment. For the O-glycoproteome, NP enrichment alone outperformed NP+MAX, suggesting that MAX may preferentially enrich N-glycopeptides. We also generated the first application of multinanoparticle protein corona enrichment to analyze CSF, another biofluid of interest for biomarker discovery, and found that NP enrichment increased proteome and glycoproteome depth, with notable identification of extracellular vesicle protein biomarkers. Overall, this study highlights the synergy of protein level enrichment with MNPPC and glycopeptide enrichment for enhancing the glycoproteome coverage of human biofluids and provides a valuable framework for studying glycoproteins in complex biological samples.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.